December 20, 2004 Dynavax Announces Interim Analysis From Ragweed Allergy Phase 2/3 Trial December 09 , 2004 Dynavax Announces Positive Interim Results From Phase 2/3 Hepatitis B Vaccine Trial December 7, 2004 Red herring selects Motia for prestigious red herring top 100 innovators award November 30, 2004 Airwide solutions and data service sign cooperative partnership November 5, 2004 Proximities completes $4 million series B financing November 3 , 2004 Industry Veteran Dave Krystowiak Joins Open Solutions’ Senior Management October 29, 2004 Open Solutions Completes Acquisition of Datawest October 25, 2004 Shopping.com Announces Initial Public Offering October 25, 2004 Airwide solutions launches new CDMA over the air solution - Airactive October 21, 2004 Open Solutions reports record third quarter 2004 revenues and net income up 63% and 455%; signed contract value for the third quarter increased 95% over the prior year October 20, 2004 Motia names Malcolm Caraballo president and CEO September 28, 2004 CipherOptics secures $10.3 million Series C financing led by Adams Capital Management September 13, 2004 Cellomics Launches 'Club HCS' Interactive User Forum and On-line Resource Center September 2, 2004 Dynavax Announces Completion of Enrollment of Phase II/III Hepatitis B Prophylactic Vaccine Trial August 26, 2004 Open Solutions Inc. Announces Plans To Acquire Datawest Solutions Inc. August 5, 2004 Dynavax Reports 2004 Second Quarter Results July 23, 2004 Open Solutions Acquires Omega Systems Corporation of North America, LLC July 23, 2004 Open Solutions Inc. Announces Exercise of Underwriters’ Overallotment Option July 20, 2004 Open Solutions Chairman & CEO Louis Hernandez, Jr. Named Finalist Of Ernst & Young Entrepreneur Of The Year® 2004 Award July 13, 2004 CiDRA Selected to receive 2004 R&D 100 Award July 6, 2004 Chiron Acquires Sagres Discovery June 29, 2004 Cellomics and GE Healthcare Collaborate To Provide Faster and More Effective Cellular Screening Solutions June 24 , 2004 Dynavax Completes Phase I Immunization in Pediatric Ragweed Allergy Trial June 21, 2004 Motia Secures $12 Million in Third Round Financing June 18 , 2004 Open Solutions Inc. Acquires EastPoint Technologies, LLC; Financial Services Provider Expands Market Presence June 15 , 2004 Open Solutions Informed of Pending Distribution of Shares of Common Stock by Menlo Ventures June 8, 2004 Open Solutions Inc. Announces Exercise of Underwriters’ Overallotment Option April 29, 2004 Anika Therapeutics Posts Profitable 2004 First Quarter; Reports 81% Revenue Increase to $6.1 MillionApril 22, 2004 Open Solutions Files Registration Statement for Public Offering of Common Stock April 22, 2004 Open Solutions Reports Strong First Quarter 2004 Results March 31, 2004 Motia Awarded 2003 “Startup of the Year” Award at 14th Annual EDN Innovation and Innovator of the Year Awards Ceremony March 29, 2004 WiDeFi Secures $6.8 Million in Venture Capital March 11,2004 Samuel F. McKay, Co-founder and General Partner of Axiom Venture Partners, recipient of Connecticut Innovations, Inc. Special Achievement Award March 9, 2004 Aspreva Pharmaceuticals Completes First-Round Equity Financing, Raising US$57million February 25, 2004 Dynavax Initiates Phase II/III Clinical Trial for Ragweed Allergy Immunotherapy February 24, 2004 Algorx Pharmaceuticals Raises $65 Million In Series C Financing Led By Advent International February 24, 2004 Dynavax Announces Exercise of Underwriters' Over-Allotment Option February 18, 2004 Dynavax Prices IPO at $7.50 Per Share February 18, 2004 SPS Commerce Forges Reseller Agreement With Quantum Software Corporation February 5, 2004 Dynavax Announces Strategic Partnering Agreement with UCB Pharma for Development and Commercialization of Seasonal Allergy Products February 5, 2004 FDA Approves ORTHOVISC for Treating Osteoarthritis of the Knee; Anika to Receive $20 Million Milestone Payment from U.S. Marketing Partner January 8, 2004 World Renowned Ribosome Expert Dr. Venki Ramakrishnan Joins Rib-X Pharmaceuticals' Scientific Advisory Board January 7, 2004 Open Solution Inc.'s fti/Financial Technologies Signs Twelve New Clients January 6, 2004 Dr. George M. Milne, Jr. Joins Rib-X Pharmaceuticals Board Of Directors